ProfileGDS5822 / ILMN_2638598
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 46% 19% 34% 31% 9% 36% 35% 31% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 120.346
GSM1276600PDAC Late Ablation Control 214.519
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 114.534
GSM1276603PDAC Late Ablation 215.331
GSM1276604PDAC Late Ablation 37.69
GSM1303940PDAC Late Ablation_anti-CTLA4 117.236
GSM1303941PDAC Late Ablation_anti-CTLA4 216.835
GSM1303942PDAC Late Ablation_anti-CTLA4 315.131